Investig Clin Urol.  2020 Sep;61(5):482-490. 10.4111/icu.20200018.

Multi-scale tissue architecture analysis of favorable-risk prostate cancer: Correlation with biochemical recurrence

Affiliations
  • 1Department of Urology, General Hospital Celje, Celje, Slovenia
  • 2Department of Integrative Oncology, BC Cancer, Vancouver, BC, Canada
  • 3Department of Radiation Oncology, BC Cancer, Vancouver, BC, Canada
  • 4Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Abstract

Purpose
Prostate cancer (PCa) with biopsy-based grade group (GG) 1 or 2 characteristics has a favorable outcome, yet some cases still progress after radical prostatectomy and present with biochemical recurrence (BCR). We hypothesized that the multi-scale tissue architecture (MSTA) analysis score would correlate with the aggressive PCa phenotype and could be used as a tool for risk assessment to improve the management of patients with favorable-risk PCa.
Materials and Methods
MSTA was evaluated in needle-biopsy samples from 115 patients with favorable-risk PCa, as defined by GG1 and GG2, a prostate-specific antigen (PSA) level of <10 ng/mL, a clinical stage of cT1c to cT2b, and general Gleason GG (GGG) and expert pathologist-assessed GG (EGG). Algorithms based on Voronoi diagrams were applied to all Feulgen-thionin-stained diagnostic areas. One hundred tissue architecture features were calculated and an MSTA score, a linear combination of the most discriminant features, was generated. Correlation of MSTA score with BCR and other clinical variables was investigated.
Results
In a univariate regression model, EGG, clinical stage, and MSTA were significant predictors of BCR (respective p-values:0.0016, 0.016, and 0.028). Survival analysis showed that patients with a high MSTA score were more likely to experience BCR than were patients with a low MSTA score (odds ratio, 2.9). Combining MSTA with GG assessment resulted in a significant stratification of risk for BCR.
Conclusions
MSTA score could be used as an objective adjunct risk stratification tool to pathologist assessments and could improve the management of patients with favorable-risk PCa.

Keyword

Biochemical recurrence; Image biomarkers; Prostate cancer; Tissue architecture analysis
Full Text Links
  • ICU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr